GlassScriptPhysician profile
Kenneth Bryce Gordon
NPI 1497752208
$2,152.76
in general payments reported to CMS, 2019-2025
11 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $275 · 2021: $223 · 2022: $229 · 2023: $266 · 2024: $283 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $889.47 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $661.27 | 2022-2025 | Infuse |
| Alcon Vision LLC | $337.45 | 2019-2025 | Precision7, Total30, Dailies Total1 |
| Thea Pharma INC. | $49.77 | 2022-2023 | |
| Abbvie INC. | $49.38 | 2022 | |
| Allergan, INC. | $48.49 | 2021 | |
| Oyster Point Pharma, INC. | $34.98 | 2023 | Tyrvaya |
| Coopervision INC. | $29.64 | 2019 | |
| Biotissue Holdings INC. | $19.37 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $18.44 | 2022 | |
| Oasis Medical, INC. | $14.50 | 2023 | Oasis Tears |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.